Saturday, September 30, 2006

Standards for e-Prescribing and Medication Management

/* NOTE: This page is very much a "work in progress." Suggestions appreciated. */

General References:

The Commission for Systemic Interoperability's publication "Ending the Document Game" has a 41 page appendix (Appendix C) summarizing all standards up to their 2005 report. This is among the most thoughtful, historical, and comprehensive summaries available.

NCVHS (2/2/2004 note to Secretary Thompson) identified three types of standards:

Message format standards

Continuity of Care Record (CCR)

NCPDP Script telecommunications

NCPDP Script formulary and benefit information

This standard displays the formulary status and alternative drugs as well as co-pays and other status information

NCPDP Script medication history

Includes the status, provider, patient, coordination of benefit, repeatable
drug, request, and response segments of SCRIPT

NCPDP Script fill status

Informs when Rx filled, not filled, or partially filled. Includes provider,
patient, and drug segments of SCRIPT message. Not yet generally used.

NCPDP Script change request and response

This the primary means by which a pharmacy may request of a provider a
clarification, correction, or change in drug as a result of therapeutic
substitution or other rationale.

NDPDP Script cancellation

Cancels a prescription previously sent to a pharmacy. Not generally used at
present.

SIG messages

Indication, dose, dose calculation, dose restriction, route, frequency,
interval, site, administration time and duration, stop

X-12N-270/271 - eligibility

X12N-278 prior authorization

This is the portion of X12-278 that supports prior authorization. It required
header information, requester, subscriber, utilization management, and other
relevant information.


Terminology standards

RxNorm

RxNorm is organized around normalized names for clinical drugs. These names
contain information on ingredients, strengths, and dose forms. It includes the
sematic clinical drug (ingredient plus strength and dose form) and the sematic
branded drug representation (proprietary, branded ingredient plus strength)

Identifier standards

Other Sites:

0 Comments:

Post a Comment

<< Home